Welcome to LookChem.com Sign In|Join Free

CAS

  • or

56558-30-6

Post Buying Request

56558-30-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56558-30-6 Usage

Chemical Properties

White to off-white powder

Uses

(S)-Methyl 2-Aminopentanoate Hydrochloride can be prepared to use as a pesticides.

Check Digit Verification of cas no

The CAS Registry Mumber 56558-30-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,5,5 and 8 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 56558-30:
(7*5)+(6*6)+(5*5)+(4*5)+(3*8)+(2*3)+(1*0)=146
146 % 10 = 6
So 56558-30-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO2.ClH/c1-3-4-5(7)6(8)9-2;/h5H,3-4,7H2,1-2H3;1H/t5-;/m0./s1

56558-30-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl norvalinate hydrochloride

1.2 Other means of identification

Product number -
Other names methyl (2S)-2-aminopentanoate,hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56558-30-6 SDS

56558-30-6Synthetic route

methanol
67-56-1

methanol

L-Norvaline
6600-40-4

L-Norvaline

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

Conditions
ConditionsYield
With hydrogenchloride Ambient temperature;98%
With hydrogenchloride for 1h; Reflux;98%
With hydrogenchloride for 6h; Reflux; Inert atmosphere;97%
tert-butyl-(2S,3S)-1,2-dihydroxyhexan-3-ylcarbamate
220515-19-5

tert-butyl-(2S,3S)-1,2-dihydroxyhexan-3-ylcarbamate

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: NaIO4; RuCl3*3H2O / acetonitrile; CCl4; H2O / 2 h
1.2: 65 percent / 3N HCl / tetrahydrofuran / 12 h / Heating
2.1: SOCl2 / 60 h / Heating
View Scheme
L-Norvaline
6600-40-4

L-Norvaline

acetyl chloride
75-36-5

acetyl chloride

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

Conditions
ConditionsYield
In methanol for 19h; Heating / reflux;
L-Norvaline
6600-40-4

L-Norvaline

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

Conditions
ConditionsYield
In methanol
methanol
67-56-1

methanol

L-norvaline hydrochloride
27493-23-8

L-norvaline hydrochloride

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

Conditions
ConditionsYield
With thionyl chloride at 40℃; Cooling with ice;
(2S,4R)-1-((S)-2-tert-Butoxycarbonylamino-3-methyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carboxylic acid
445306-02-5

(2S,4R)-1-((S)-2-tert-Butoxycarbonylamino-3-methyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carboxylic acid

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

(S)-2-{[(2S,4R)-1-((S)-2-tert-Butoxycarbonylamino-3-methyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-pentanoic acid methyl ester

(S)-2-{[(2S,4R)-1-((S)-2-tert-Butoxycarbonylamino-3-methyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-pentanoic acid methyl ester

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 2.5h;95%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

methyl N-{[(1,1-dimethylethyl)oxy]carbonyl}-L-norvalinate
64896-37-3

methyl N-{[(1,1-dimethylethyl)oxy]carbonyl}-L-norvalinate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃;93%
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

(S)-2-((S)-2-tert-Butoxycarbonylamino-3-methyl-pentanoylamino)-pentanoic acid methyl ester

(S)-2-((S)-2-tert-Butoxycarbonylamino-3-methyl-pentanoylamino)-pentanoic acid methyl ester

Conditions
ConditionsYield
With 1-[bis(dimethylamino)methylen]-1-H-benzotriazolim-tetrafluoroborate-3-oxide; N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20℃;92%
With triethylamine; diethyl dicarbonate In N,N-dimethyl-formamide at 0 - 20℃; for 2.5h;74%
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

trifluoroacetic anhydride
407-25-0

trifluoroacetic anhydride

(S)-methyl 2-(2,2,2-trifluoroacetamido)pentanoate
74538-84-4

(S)-methyl 2-(2,2,2-trifluoroacetamido)pentanoate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 23℃; for 5h;89%
With 4-methyl-morpholine In chloroform
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

5-(cyclopropanecarbonyl)-2,2-dimethyl-1,3-dioxane-4,6-dione
134302-11-7

5-(cyclopropanecarbonyl)-2,2-dimethyl-1,3-dioxane-4,6-dione

methyl 2-(3-cyclopropyl-3-oxopropionamido)pentanoate

methyl 2-(3-cyclopropyl-3-oxopropionamido)pentanoate

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane at 110℃; for 4h;86%
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

5-acetyl-2,2-dimethyl-1,3-dioxane-4,6-dione
72324-39-1

5-acetyl-2,2-dimethyl-1,3-dioxane-4,6-dione

methyl 2-(3-oxobutanamido)pentanoate
128892-47-7

methyl 2-(3-oxobutanamido)pentanoate

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane at 110℃; for 4h;86%
4-methyleneoxetan-2-one
674-82-8

4-methyleneoxetan-2-one

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

methyl 2-(3-oxobutanamido)pentanoate
128892-47-7

methyl 2-(3-oxobutanamido)pentanoate

Conditions
ConditionsYield
With triethylamine In chloroform; acetone for 16h; Ambient temperature;83%
With triethylamine In methanol at -4℃; for 1h;
5-[3-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)propyl]thiophene-2-carboxylic acid
1219915-50-0

5-[3-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)propyl]thiophene-2-carboxylic acid

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

C20H25N5O4S

C20H25N5O4S

Conditions
ConditionsYield
Stage #1: 5-[3-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)propyl]thiophene-2-carboxylic acid With 4-methyl-morpholine; 2-chloro-4,6-dimethoxy-1 ,3,5-triazine In N,N-dimethyl-formamide at 20℃; for 2h;
Stage #2: methyl L-norvalinate hydrochloride In N,N-dimethyl-formamide at 20℃; for 12h;
83%
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

5-(cyclohexanecarbonyl)-2,2-dimethyl-1,3-dioxane-4,6-dione
112378-35-5

5-(cyclohexanecarbonyl)-2,2-dimethyl-1,3-dioxane-4,6-dione

methyl 2-(3-cyclohexyl-3-oxopropionamido)pentanoate

methyl 2-(3-cyclohexyl-3-oxopropionamido)pentanoate

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane at 110℃; for 4h;83%
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
59-05-2

N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid

methyl 2-({N2-{4-[[(2,4-diaminopteridin-6-yl)methyl](methyl)amino]benzoyl}-N1-[1-(methoxycarbonyl)propyl]-α-glutaminyl}amino)pentanoate

methyl 2-({N2-{4-[[(2,4-diaminopteridin-6-yl)methyl](methyl)amino]benzoyl}-N1-[1-(methoxycarbonyl)propyl]-α-glutaminyl}amino)pentanoate

Conditions
ConditionsYield
With 1-hydroxybenzotriazol-hydrate; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 26h;81%
N-tert-butoxycarbonyl-L-leucine
13139-15-6

N-tert-butoxycarbonyl-L-leucine

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

(N-(tert-butoxycarbonyl)-L-leucinyl)-L-norvaline methyl ester
1426227-61-3

(N-(tert-butoxycarbonyl)-L-leucinyl)-L-norvaline methyl ester

Conditions
ConditionsYield
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;80.9%
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;692 mg
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

benzyl chloroformate
501-53-1

benzyl chloroformate

benzyl N-[(1S)-1-(hydroxymethyl)butyl]carbamate
145842-50-8

benzyl N-[(1S)-1-(hydroxymethyl)butyl]carbamate

Conditions
ConditionsYield
Stage #1: methyl L-norvalinate hydrochloride; benzyl chloroformate With potassium carbonate In tetrahydrofuran; water at 20℃; for 4h;
Stage #2: With methanol; sodium tetrahydroborate In tetrahydrofuran at 10 - 25℃; for 2h;
73%
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

benzyl bromide
100-39-0

benzyl bromide

methyl 2-(benzylamino)pentanoate

methyl 2-(benzylamino)pentanoate

Conditions
ConditionsYield
With potassium carbonate In acetonitrile at 20℃;73%
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

4(S)-N-chloroformyl-4-isopropyl-2-oxazolidinone
153896-97-0

4(S)-N-chloroformyl-4-isopropyl-2-oxazolidinone

(S)-2-[((S)-4-Isopropyl-2-oxo-oxazolidine-3-carbonyl)-amino]-pentanoic acid methyl ester

(S)-2-[((S)-4-Isopropyl-2-oxo-oxazolidine-3-carbonyl)-amino]-pentanoic acid methyl ester

Conditions
ConditionsYield
With sodium hydroxide In dichloromethane; water 0 deg C, 30 min, RT, 1 h;71%
2-Picolinic acid
98-98-6

2-Picolinic acid

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

(S)-methyl 2-(picolinamido)pentanoate
1353864-09-1

(S)-methyl 2-(picolinamido)pentanoate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;71%
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

N-(dodecyloxycarbonyl)-(L-phenylalanyl)-L-histidine

N-(dodecyloxycarbonyl)-(L-phenylalanyl)-L-histidine

N-(dodecyloxxyycarbonyl)-(L-phenylalanyl)-L-histidyl-L-norvaline methyl ester

N-(dodecyloxxyycarbonyl)-(L-phenylalanyl)-L-histidyl-L-norvaline methyl ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In N,N-dimethyl-formamide66%
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

C22H13F2N3O6

C22H13F2N3O6

methyl(S)-2-((S)-2-(2,4-dinitrophenyl)-2-(4-fluorobenzamido)-3-(3-fluorophenyl)propanamido)pentanoate

methyl(S)-2-((S)-2-(2,4-dinitrophenyl)-2-(4-fluorobenzamido)-3-(3-fluorophenyl)propanamido)pentanoate

Conditions
ConditionsYield
With dmap; potassium carbonate In chloroform at 20℃; for 16h;63%
N-ethoxycarbonylphthalimide
22509-74-6

N-ethoxycarbonylphthalimide

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

(S)-N-Phthaloylnorvaline Methyl Ester
137649-34-4

(S)-N-Phthaloylnorvaline Methyl Ester

Conditions
ConditionsYield
With sodium carbonate In water55%
CF3O3S(1-)*C14H18BrN4O2S(1+)
948902-44-1

CF3O3S(1-)*C14H18BrN4O2S(1+)

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

C16H24BrN3O4S
948902-45-2

C16H24BrN3O4S

Conditions
ConditionsYield
With triethylamine In acetonitrile at 20℃; for 40h;53.8%
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

biotin
58-85-5

biotin

(S)-2-[5-((3aR,6S,6aS)-2-Oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentanoylamino]-pentanoic acid methyl ester

(S)-2-[5-((3aR,6S,6aS)-2-Oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentanoylamino]-pentanoic acid methyl ester

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide for 4h;50%
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

(S)-N-(2,6-dioxo-tetrahydro-2H-pyran-3-yl)-3,4,5-trimethoxybenzamide
731798-31-5

(S)-N-(2,6-dioxo-tetrahydro-2H-pyran-3-yl)-3,4,5-trimethoxybenzamide

(S)-2-[(S)-4-Carboxy-2-(3,4,5-trimethoxy-benzoylamino)-butyrylamino]-pentanoic acid methyl ester

(S)-2-[(S)-4-Carboxy-2-(3,4,5-trimethoxy-benzoylamino)-butyrylamino]-pentanoic acid methyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 1.16667h;47%
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

3,5-difluorophenyl acetic acid
105184-38-1

3,5-difluorophenyl acetic acid

C14H17F2NO3
681143-31-7

C14H17F2NO3

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine In dichloromethane at 20℃;36%
C15H17NO7
1155873-40-7

C15H17NO7

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

(R)-5-((S)-1-methoxy-1-oxopentan-2-ylamino)-5-oxo-4-(3,4,5-trimethoxybenzamido)pentanoic acid
1331960-95-2

(R)-5-((S)-1-methoxy-1-oxopentan-2-ylamino)-5-oxo-4-(3,4,5-trimethoxybenzamido)pentanoic acid

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃;23.4%
N-(tert-butyloxycarbonyl) azide
1070-19-5

N-(tert-butyloxycarbonyl) azide

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

methyl N-{[(1,1-dimethylethyl)oxy]carbonyl}-L-norvalinate
64896-37-3

methyl N-{[(1,1-dimethylethyl)oxy]carbonyl}-L-norvalinate

Conditions
ConditionsYield
With 4-methyl-morpholine In ethyl acetate
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

N-tert-butoxycarbonyl-L-norvaline
53308-95-5

N-tert-butoxycarbonyl-L-norvaline

(S)-2-((S)-2-tert-Butoxycarbonylamino-pentanoylamino)-pentanoic acid methyl ester
56558-25-9

(S)-2-((S)-2-tert-Butoxycarbonylamino-pentanoylamino)-pentanoic acid methyl ester

Conditions
ConditionsYield
(i) 4-methyl-morpholine, CHCl3, (ii) /BRN= 3607582/, DCC; Multistep reaction;
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

acetyl chloride
75-36-5

acetyl chloride

methyl (S)-2-(N-acetylamino)pentanoate
1492-17-7

methyl (S)-2-(N-acetylamino)pentanoate

Conditions
ConditionsYield
With triethylamine In chloroform
2-phenyl-4-iso-propyl-4H-oxazolin-5-one
28897-81-6, 51127-17-4, 85700-33-0, 5839-93-0

2-phenyl-4-iso-propyl-4H-oxazolin-5-one

methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

A

Bz-D-Val-L-Nle-OCH3

Bz-D-Val-L-Nle-OCH3

B

Bz-L-Val-L-Nle-OCH3

Bz-L-Val-L-Nle-OCH3

Conditions
ConditionsYield
With triethylamine In dichloromethane at 5℃; for 24h; Product distribution; asymmetric induction during aminolysis; other solvent;
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

4-isobutyl-2-phenyloxazol-5(4H)-one
25163-98-8, 27460-46-4, 35253-83-9

4-isobutyl-2-phenyloxazol-5(4H)-one

A

Bz-L-Leu-L-Nle-OCH3

Bz-L-Leu-L-Nle-OCH3

B

Bz-D-Leu-L-Nle-OCH3

Bz-D-Leu-L-Nle-OCH3

Conditions
ConditionsYield
With triethylamine In dichloromethane at 5℃; for 24h; Product distribution; asymmetric induction during aminolysis;
methyl L-norvalinate hydrochloride
56558-30-6

methyl L-norvalinate hydrochloride

6-chloro-2-methoxy-9-phenoxyacridine
7478-26-4

6-chloro-2-methoxy-9-phenoxyacridine

(S)-2-(6-Chloro-2-methoxy-acridin-9-ylamino)-pentanoic acid methyl ester; hydrochloride
144862-87-3

(S)-2-(6-Chloro-2-methoxy-acridin-9-ylamino)-pentanoic acid methyl ester; hydrochloride

Conditions
ConditionsYield
With phenol at 120℃; for 2.5h;

56558-30-6Relevant articles and documents

PARP1 INHIBITORS

-

Page/Page column 36-37, (2021/01/29)

The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine. Formula (I)

Regiodivergent Enantioselective γ-Additions of Oxazolones to 2,3-Butadienoates Catalyzed by Phosphines: Synthesis of α,α-Disubstituted α-Amino Acids and N,O-Acetal Derivatives

Wang, Tianli,Yu, Zhaoyuan,Hoon, Ding Long,Phee, Claire Yan,Lan, Yu,Lu, Yixin

supporting information, p. 265 - 271 (2016/01/25)

Phosphine-catalyzed regiodivergent enantioselective C-2- and C-4-selective γ-additions of oxazolones to 2,3-butadienoates have been developed. The C-4-selective γ-addition of oxazolones occurred in a highly enantioselective manner when 2-aryl-4-alkyloxazol-5-(4H)-ones were employed as pronucleophiles. With the employment of 2-alkyl-4-aryloxazol-5-(4H)-ones as the donor, C-2-selective γ-addition of oxazolones took place in a highly enantioselective manner. The C-4-selective adducts provided rapid access to optically enriched α,α-disubstituted α-amino acid derivatives, and the C-2-selective products led to facile synthesis of chiral N,O-acetals and γ-lactols. Theoretical studies via DFT calculations suggested that the origin of the observed regioselectivity was due to the distortion energy that resulted from the interaction between the nucleophilic oxazolide and the electrophilic phosphonium intermediate.

Crucial role of β-elimination in determining regio- and chemoselectivity of the rhodium-catalyzed hydroformylation of N -allylpyrroles: A new approach to 5,6-dihydroindolizines

Settambolo, Roberta

scheme or table, p. 2915 - 2921 (2010/10/21)

Rhodium-catalyzed hydroformylation of the chiral (S)-3-alkyl-3-pyrrol-1- ylprop-1-enes at 100 atmospheres total pressure and 25C led to the preferential formation of the branched 3-alkyl-2-methyl-3-pyrrol-1-ylpropanals. At 30 atmospheres and 125°C, the linear 4-alkyl-4-pyrrol-1-ylbutanals were obtained: these aldehydes are not the final products, but evolve into more stable 5,6-dihydroindolizines, with the same optical purity as the starting olefins, via a domino cyclization-dehydration process. According to the generally accepted mechanism for rhodium-catalyzed hydroformylation, the regioselectivity, and then the final chemoselectivity, can be rationalized by taking into account that while at room temperature no -elimination occurs, at high temperature the -elimination involves the branched rhodium-alkyl intermediate only.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 56558-30-6